Edison, NJ, United States of America

Fuqiang Liu


Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Piscataway, NJ (US) (2002)
  • Edison, NJ (US) (2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fuqiang Liu: Innovator in Cancer Treatment

Introduction

Fuqiang Liu is a prominent inventor based in Edison, New Jersey. He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. With a total of two patents to his name, Liu focuses on advancing therapeutic approaches to combat cancer.

Latest Patents

Liu's latest patents include "Delivery systems and methods for noscapine and noscapine derivatives, useful as anticancer agents" and "Noscapine and noscapine derivatives, useful as anticancer agents." These patents highlight his work with compounds such as formula (I), which have shown potential in the treatment of tumor cells and cancer.

Career Highlights

Currently, Fuqiang Liu is associated with Emory University, where he continues to engage in groundbreaking research. His academic and professional journey has positioned him as a key figure in the fight against cancer, leveraging his expertise to develop effective treatment options.

Collaborations

Throughout his career, Liu has collaborated with esteemed colleagues such as Harish C. Joshi and Judith A. Kapp. These partnerships have fostered an environment of innovation, allowing for a diverse range of insights and advancements in cancer therapy.

Conclusion

In summary, Fuqiang Liu stands out as an influential inventor whose work on noscapine and its derivatives holds promise for future cancer treatments. His continued efforts at Emory University exemplify the importance of collaboration and innovation in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…